Citations of work:

Sunita Sah & Adriane Fugh-Berman (2013). Physicians Under the Influence: Social Psychology and Industry Marketing Strategies.

9 found
Order:
Are we missing citations?

PhilPapers citations & references are currently in beta testing. We expect to add many more in the future.

Meanwhile, you can use our bibliography tool to import references for this or another work.

Or you can directly add citations for the above work:

Search for work by author name and title
Add directly by record ID

  1. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.Teresa Leonardo Alves, Joel Lexchin & Barbara Mintzes - forthcoming - Science and Engineering Ethics:1-26.
    Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of (...)
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  2.  2
    Dangers of Neglecting Non-Financial Conflicts of Interest in Health and Medicine.Miriam Wiersma, Ian Kerridge & Wendy Lipworth - 2018 - Journal of Medical Ethics 44 (5):319-322.
    Non-financial interests, and the conflicts of interest that may result from them, are frequently overlooked in biomedicine. This is partly due to the complex and varied nature of these interests, and the limited evidence available regarding their prevalence and impact on biomedical research and clinical practice. We suggest that there are no meaningful conceptual distinctions, and few practical differences, between financial and non-financial conflicts of interest, and accordingly, that both require careful consideration. Further, a better understanding of the complexities of (...)
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography  
  3.  5
    Attitudes of Public Health Academics Toward Receiving Funds From for-Profit Corporations: A Systematic Review.Rima T. Nakkash, Sanaa Mugharbil, Hala Alaouié & Rima A. Afifi - 2017 - Public Health Ethics 10 (3).
    With dwindling support from governments toward universities, university–industry partnerships have increased. Ethical concerns over such partnerships have been documented, are particularly relevant when an institution receives money from a corporation whose products do harm and are intensified for academic public health institutions whose missions include promoting well-being. Academics in medicine and nutrition have often failed to recognize the potential conflicts of industry-sponsored research. It is unclear if research to date has explored attitudes of public health academics toward accepting such funds. (...)
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  4.  2
    Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest.Avinash R. Patwardhan - 2016 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 53:004695801666759.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  5.  5
    Patients' Participation in Decision-Making in the Medical Field - ‘Projectification’ of Patients in a Neoliberal Framed Healthcare System.Stinne Glasdam, Christine Oeye & Lars Thrysoee - 2015 - Nursing Philosophy 16 (4):226-238.
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography   3 citations  
  6.  1
    From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians.Amy Snow Landa & Carl Elliott - 2013 - Journal of Law, Medicine and Ethics 41 (3):673-679.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   2 citations  
  7.  1
    Five Un-Easy Pieces of Pharmaceutical Policy Reform.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):581-589.
    Direct download (3 more)  
     
    Export citation  
     
    My bibliography   7 citations  
  8.  2
    Institutional Corruption and the Pharmaceutical Policy.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):544-552.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    My bibliography  
  9.  11
    Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On.Sergio Sismondo - 2013 - Journal of Law, Medicine and Ethics 41 (3):635-643.
    The pharmaceutical industry, in its marketing efforts, often turns to “key opinion leaders” or “KOLs” to disseminate scientific information. Drawing on the author's fieldwork, this article documents and examines the use of KOLs in pharmaceutical companies’ marketing efforts. Partly due to the use of KOLs, a small number of companies with well-defined and narrow interests have inordinate influence over how medical knowledge is produced, circulated, and consumed. The issue here, as in many other cases of institutional corruption, is that a (...)
    Direct download (6 more)  
     
    Export citation  
     
    My bibliography   16 citations